Petefészekrák: nyitott vizsgálatok itt: Svájc
13 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.
2. fázisToborozTrial-stage medicine
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Bern, Geneva, Zurich
- Age
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819EU 2024-517419-62-00Regiszter frissítve: 2026-11-04
3. fázisToborozTrial-stage medicine
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Where
- Baden, Bellinzona, Chur, Geneva
- Age
- 18 év and over
- People
- 1630 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07213804EU 2025-522255-25-00Regiszter frissítve: 2026-11-04
1/2. fázisToborozTrial-stage medicine
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).
- Where
- Basel, Lausanne, Sankt Gallen
- Age
- 18 év and over
- People
- 605 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06843447EU 2024-514674-47-00Regiszter frissítve: 2026-10-30
No phaseToborozTrial-stage medicine
OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy
- Where
- Aarau, Baden, Basel, Bern, Frauenfeld, Fribourg, Lucerne, Sankt Gallen, Winterthur, Zurich
- Age
- 18 év and over
- People
- 60
- Run by
- Swiss GO Trial Group
See details and how to joinNCT06466382Regiszter frissítve: 2026-10-27
3. fázisToborozTrial-stage medicine
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Where
- Bellinzona, Chur, Frauenfeld, Geneva, Lausanne, Zurich
- Age
- 18 év and over
- People
- 466 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07214779EU 2025-522748-42-00Regiszter frissítve: 2026-10-15
3. fázisToborozTrial-stage medicine
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- Where
- Bellinzona, Bern, Chur, Geneva
- Age
- 18 év and over
- People
- 900 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07318558EU 2023-508047-40-00Regiszter frissítve: 2026-10-13
2. fázisToborozTrial-stage medicine
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Basel, Bellinzona, Sankt Gallen
- Age
- 18 év to 130 év
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211EU 2023-509436-26-00Regiszter frissítve: 2026-09-23
2. fázisToborozTrial-stage medicine
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Where
- Bellinzona, Chur, Geneva, Lausanne
- Age
- 18 év to 99 év
- People
- 160 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07023627EU 2025-521513-14-00Regiszter frissítve: 2026-09-15
3. fázisToborozTrial-stage medicine
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Where
- Basel, Münsterlingen, Sankt Gallen, Thun, Zollikerberg, Zurich
- Age
- 18 év and over
- People
- 1100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07218809EU 2025-520466-22-00Regiszter frissítve: 2026-07-21
1. fázisToborozTrial-stage medicine
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Chur, Lausanne
- Age
- 18 év and over
- People
- 1006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632EU 2023-508469-34-00Regiszter frissítve: 2026-07-06
No phaseToborozResearch participation
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
- Where
- Basel, Bellinzona, Bern, Delémont, Fribourg, Geneva, Winterthur
- Age
- 18 év and over
- People
- 700
- Run by
- University of Basel
See details and how to joinNCT03124212Regiszter frissítve: 2026-05-13
No phaseToborozResearch participation
The Immune Landscape of Epithelial Ovarian Cancer
- Where
- Bellinzona
- Age
- 18 év and over
- People
- 74
- Run by
- Oncology Institute of Southern Switzerland
See details and how to joinNCT05984875Regiszter frissítve: 2025-11-18
3. fázisToborozTrial-stage medicine
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
- Where
- Aarau, Baden, Basel, Bellinzona, Bern, Chur, Frauenfeld, Geneva, Grabs, Lausanne, Liestal, Lucerne, Münsterlingen, Sankt Gallen, Sion, Winterthur, Zurich
- Age
- 18 év and over
- People
- 540 worldwide
- Run by
- Swiss GO Trial Group
See details and how to joinNCT04111978EU 2024-511219-78-00Regiszter frissítve: 2025-09-29
Minden vizsgálat (Petefészekrák) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.